Anserine
|
Basic information |
| Metabolite name | Anserine |
 | HMDB0000194 |
 |
C01262 |
 |
112072 |
| Synonyms | Beta-alanyl-3-methyl-L-histidine |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Anserine |
| HMDB0000194 |
|
C01262 |
|
112072 |
| Synonyms | Beta-alanyl-3-methyl-L-histidine |
| No. of studies | 8 |
|
Relationship between Anserine and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1090 | Type3 | hyperbaric oxygen treatment group vs. control group | Plasma | BALb/c mouse | Up |
| Study M528 | Type2 | CUS + fluoxetine group vs. CUS group | Frontal cortex | FVB mouse | Up |
| Study M737 | Type1 | IBS-D group vs. control group | Urine | Human | Down |
| Study M740 | Type1 | CUMS group vs. control group | Gastrocnemius muscle | Sprague-Dawley rat | Down |
| Study M740 | Type1 | CUMS group vs. control group | Soleus muscle | Sprague-Dawley rat | Down |
| Study M740 | Type2 | CUMS + endurance exercise group vs. CUMS group | Gastrocnemius muscle | Sprague-Dawley rat | Up |
| Study M740 | Type2 | CUMS + endurance exercise group vs. CUMS group | Soleus muscle | Sprague-Dawley rat | Up |
| Study M836 | Type1 | CRS group vs. control group | Serum | C57BL/6 mouse | Down |
| Study M836 | Type2 | CRS + Akkermansia muciniphila group vs. CRS group | Serum | C57BL/6 mouse | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Up |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |